Jamie A. Donadio, Senior VP, CFO at Mirati Therapeutics, Inc. (MRTX), sold 77,650 shares at $26.78 ($2.1M) on 2018-03-01, disclosed to the SEC on 2018-03-02.
Open-market sale of $2.1M MRTX by Senior VP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.78 | 25,600 | $686K | 32.4% |
| 2 | $27.45 | 25,775 | $708K | 33.5% |
| 3 | $27.45 | 25,775 | $708K | 33.5% |
| 4 | $28.08 | 500 | $14K | 0.7% |
| Total | $27.23 avg | 77,650 | $2.1M | 100% |
| Filing → |
| MRTX | SELL | 2018-03-13 | $424K | — | Filing → |